COVID-19 Research Updates Featuring Dr. Josef Penninger


Dr. Josef Penninger is the Director of both the Life Sciences Institute at the University of British Columbia and the Institute for Molecular Biotechnology of the Austrian Academy of Sciences in Vienna, Austria. He was previously on The Stem Cell Podcast to talk about his research developing human blood vessel organoids. In 2020, Dr. Penninger’s team identified a trial drug that can significantly block early stages of COVID-19 infection in human blood vessel and kidney organoids.

Find more episodes at stemcellpodcast.com or wherever you get your podcasts.


In Vitro Modeling for Developing COVID-19 Therapeutics

Learn more about Dr. Penninger’s COVID-19 research and his experience with organoids.

Read Dr. Penninger’s Profile >

This Episode's Science Round Up:

  • COVID Drugs Cause Heart Abnormalities – Hydroxychloroquine and azithromycin have been considered possible drugs for COVID-19, but patients treated with the drugs had prolonged QT intervals that can lead to arrhythmias and sudden cardiac death.
  • Monkeys Protected by COVID-19 Vaccine – For the first time, a COVID-19 vaccine candidate has protected rhesus macaques from being infected by the SARS-CoV-2 virus.
  • New, Rapid COVID-19 Test – A new diagnostic test for COVID-19 has been established that uses CRISPR-Cas12 to identify the SARS-CoV-2 virus in samples in less than 40 minutes.
  • SARS-CoV-2 Mapped Out – Investigators have generated a high-resolution map of the SARS-CoV-2 transcriptome and epitranscriptome, gaining insights into unknown RNA transcripts and RNA modification sites.
  • Cell Likely Targeted by the COVID-19 Virus – Researchers have uncovered subsets of cells in the lung, the nasal passages, and the intestine that co-express ACE2 and TMPRSS2, which promote cellular entry of SARS-CoV-2.
  • Nose Cells Identified as Likely COVID-19 Virus Entry Point – High expression levels of two viral entry-associated genes have been found in nasal epithelial cells, highlighting the cells’ potential role in initial viral infection.
  • Heart Model for COVID-19 Infection – To study cardiomyocyte-specific infection by SARS-CoV-2, scientists have developed a model system using iPSC-derived cardiomyocytes that is susceptible to infection and expresses low levels of ACE2.

Tools for COVID-19 Research

Having the right tools and support is essential for accelerating scientific discovery for COVID-19 and SARS-CoV-2. As Scientists Helping Scientists, we are here to help with relevant tools, products, and support for your research.

Related Resources

Publish Date: May 19, 2020

Contact STEMCELL Technologies

Our Customer Service, Sales, and Product and Scientific Support departments in North America are available between 6 am and 5 pm Pacific Time (9 am and 8 pm Eastern Time). One of our representatives will be happy to help you by telephone or email. Please complete the form to contact us by email. A representative will get back to you shortly.
  •  

StemCell Technologies Inc. and affiliates ("STEMCELL Technologies") does not share your email address with third parties. StemCell Technologies Inc. will use your email address to confirm your identity and send you newsletters, transaction-related emails, promotional and customer service emails in accordance with our privacy policy. You can change your email preferences at any time.